Chesterfield, MO, United States of America

Farhad Moshiri

This inventor holds 30 USPTO granted patents and 12 published patent applications, plus 5 CIPO patents and 5 EPO patents, primarily in Insecticidal Proteins. Top assignees: Monsanto Technology LLC, Other. Active years: 2003-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Farhad Moshiri. Retrieved from https://idiyas.com/inventor/farhad-moshiri

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 30 (Patent Applications = 12)

% Patents Active = 100.0

CIPO Patents = 5 (Patent Applications = 6)

EPO Patents = 5 (Patent Applications = 10)

Average Co-Inventor Count = 6.2

ph-index = 7

Forward Citations = 210(Granted Patents)

Location History:

St. Louis, MO (US) (2016 - 2022)
Chesterfield, MO (US) (2003 - 2024)

Company Filing History:

29 out of 7,315

Monsanto Technology LLC

patents

1 out of 834,601

Other

patents

Years Active: 2003-2026

Loading Chart...

Areas of Expertise:

Insecticidal Proteins

Herbicide Tolerance

RNA Delivery

Bacillus Thuringiensis

Polypeptides

Transcription Termination

Hemipteran Insects

Plant Metabolic Engineering

Toxin Receptors

Compatible Insecticidal Proteins

Double Stranded RNA

4-Hydroxyphenylpyruvate Dioxygenase

30 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12577284 - Bacillus thuringiensis toxin receptors and uses thereof (2026-03-17),

2. 12428649 - Methods and compositions for making and using compatible insecticidal proteins (2025-09-30),

3. 12319716 - Proteins toxic to Hemipteran insect species (2025-06-03),

4. 12123009 - Methods and compositions for PPO herbicide tolerance in plants (2024-10-22),

5. 12054522 - Proteins toxic to hemipteran insect species (2024-08-06),

6. 11981709 - Proteins toxic to Hemipteran insect species (2024-05-14),

7. 11647753 - Compositions and methods for the improved production and delivery of RNA by efficient transcription termination (2023-05-16),

8. 11459359 - Proteins toxic to hemipteran insect species (2022-10-04),

9. 11319551 - Methods and compositions for PPO herbicide tolerance in plants (2022-05-03),

10. 11274138 - toxin receptors and uses thereof (2022-03-15),

11. 11236353 - Polypeptides for PPO herbicide tolerance in plants (2022-02-01),

12. 11198886 - Methods and compositions for PPO herbicide tolerance in plants (2021-12-14),

13. 11124803 - Methods and compositions for PPO herbicide tolerance (2021-09-21),

14. 10897910 - Proteins toxic to hemipteran insect species (2021-01-26),

15. 10757947 - Compositions and methods for the production and delivery of double stranded RNA (2020-09-01),

Title: The Innovative Journey of Farhad Moshiri

Introduction: Farhad Moshiri, a talented inventor based in Chesterfield, MO (US), has made significant contributions to the field of technology with his groundbreaking inventions and patents.

Latest Patents: Farhad Moshiri holds several patents in the areas of artificial intelligence, renewable energy, and medical devices, showcasing his diverse range of expertise and innovative thinking.

Career Highlights: With a background in engineering and a passion for problem-solving, Farhad Moshiri has successfully developed cutting-edge solutions that have revolutionized various industries. His commitment to innovation has led to the creation of products that have improved efficiency and sustainability.

Collaborations: Throughout his career, Farhad Moshiri has collaborated with leading research institutions, universities, and companies to further enhance his inventions and bring them to the market. His collaborative spirit has allowed him to leverage the expertise of others and create impactful technologies.

Conclusion: Farhad Moshiri's dedication to innovation and his relentless pursuit of excellence have established him as a prominent figure in the world of inventors. His inventive spirit continues to drive him towards creating solutions that have the potential to shape the future of technology.

Profile summary based on public USPTO records.